"Texas Oncology is an independent private practice with more than 500 physicians and 210 locations across the state. Meeting the oncology needs of Texans for more than 35 years, the practice includes Texas Center for Proton Therapy, Texas Breast Specialists, Texas Oncology Surgical Specialists, and Texas Center for Interventional Surgery. As a lead participant in US Oncology Research, Texas Oncology played a role in the development of more than 100 FDA-approved therapies."

During the past decade, Texas Oncology San Antonio Northeast conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 8 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 8 clinical trials were completed. i.e. 88.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Oncology San Antonio Northeast" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Seagen Inc." with 2 trials sponsored, "Arcus Biosciences, Inc." with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Oncology San Antonio Northeast" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Janssen, LP" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Texas Oncology San Antonio Northeast" are "Advanced Solid Tumor" (2 trials), "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Multiple Myeloma" (2 trials) and "Breast Neoplasm" (1 trials). Many other conditions were trialed in "Texas Oncology San Antonio Northeast" in a lesser frequency.

Most popular intervention types in "Texas Oncology San Antonio Northeast" are "Drug" (18 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (3 trials), "Cisplatin" (2 trials), "Giredestrant" (2 trials), "LHRH Agonist" (2 trials) and "(vic-)trastuzumab duocarmazine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Texas Oncology San Antonio Northeast" are 21 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Texas Oncology San Antonio Northeast". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Texas Oncology San Antonio Northeast, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Oncology San Antonio Northeast, 4 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".